Risk Stratification of COVID-19 Using Urine Biomarkers

Status unconfirmed

Conditions studied: Covid19, Urine, Biomarker, Acute Respiratory Failure With Hypoxia

In brief

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in infected patients, it produces symptoms which range from completely asymptomatic to those expressing severe illness. Early recognition of those developing severe manifestations allows for rapid and appropriate intervention, including admission to intensive care unit and intensive care therapy, such as mechanical ventilation. A current problem is that only limited data exist predicting the clinical course of COVID-19. This study will determine whether non-invasive urinalysis is useful in assessing and predicting the severity or clinical course of patients with COVID-19.

Key facts

Study ID

NCT04681040

Run by

National Center for Global Health and Medicine, Japan

People needed

964

Starts

2020-09-15

Expected to finish

2024-03-25

Last updated by the study team

2024-03-27

Who can join

Age: 20 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• COVID-19 confirmed cases by qPCR exam or equivalent.
• Those who agreed to join this study
• Those who received treatment at NCGM, affiliated hospital and institute including accommodation facilities for observational purposes.

You may not qualify if…

• Age less than 20
• Those who do not have smart phone (no personal contract)
• eGFR less than 30
• Any pre-existing illness with fever, weakness, or respiratory difficulties, Pregnancy or breastfeeding.
• Doctors' judgements to inappropriate for inclusion

Where it is running

• MD Mount Sinai — Baltimore, Maryland, United States
• Hospital das Clinicas Ribeirao Preto — Ribeirão Preto, São Paulo, Brazil
• Danish National Biobank — Copenhagen, Denmark
• Shonan General Hospital — Kamakura, Kanagawa, Japan
• National Center Global Health and Medicine — Shinjuku, Tokyo, Japan
• Yamanashi Prefectural Central Hospital — Kofu, Yamanashi, Japan
• Unilab Group — Manila, Philippines

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.